Anavex Life Sciences Corp (AVXL)

[Gator328]

Thanks. This does not sound like it will bode well for Anavex when it has to present data to the FDA, unless there is a very good reason for changing the endpoints.

The saving grace may be the lack of other effective Rett treatments, but it seems a bit sketchy they aren't releasing the original endpoint.

I really need to start following this company more closely but these trials take so long. I admire those who are able to stay invested -- no pun intended -- in the various updates day in and day out for so many years.

As always, I appreciate your perspective.